ABSTRACT
Purpose:
To determine the incidence, risc factors and treatment results of retinopathy of premature (ROP) among premature infants followed in our clinic.
Methods:
The examination findings of premature infants followed in our clinic between December 2006 –August 2009 are evaluated. The incidence of ROP, its stage and the rate of infants who warranted treatment was determined following the grouping according to birth weight and gestational age. The hospital registrations of eighty-nine infants followed up in our neonatal unit are screened for respiratory distres syndrome (RDS), mechanical ventilation treatment, sepsis. In addition the treatment results and complications of Argon laser treatment are evaluated.
Results:
The mean gestational age and the mean birth weight of the 221 premature infants included in our study was 30.69±2.48 (23-36) weeks and 1513.75 ± 471.73 (700-3278) gr, respectively. ROP was detected in 33.5% (74/221) of premature infants followed up. Regarding the gestational age the incidence was highest among infants born before 28 weeks (54.90 %) and regarding the birth weight the incidence was highest in premature infants less than 1000gr (61.8%). Statistical analysis revealed a significant relationship between birth weight, gestational age and ROP (p
Conclusion:
As a multifactorial disease ROP composes a great risc of blindness for infants with small gestational age and low birth weight, however Argon laser treatment of eyes with ROP seems to be an effective and safe alternative.
Keywords:
Retinopathy of premature, screening results, treatment results, laser treatment
References
1Quinn GE, Retinopathy of premature. In: Yanoff M, Duker JS eds. Ophthalmology, 2nd ed, chap 309. St Louis, Mosby, 2004
2Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Z,n A; International NO-ROP Group, Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate and high levels of development: implications for screening programs Pediatrics 2005,115
3zkan H, Köksal N, Prematüre Retinopatisi Güncel Pediatri 2005,2-24
4Arsan S, Prematüre Retinopatisi T Klin Pediatri 2004,2-382
5Section on Ophthalmology, American Academy of Pediatrics, American Academy of Ophthalmology and American Association for Pediatric Ophthalmology and Strabismus, Screening Examination of Premature Infants for Retinopathy of Prematurity Pediatrics 2006,117-572
6An International Committee for the Classification of Retinopathy of Prematurity : The international classification of retinopathy of prematurity revisited, Arch Ophthalmol 2005,123-991
7Early Treatment for Retinopathy of Cooperative Group Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial, Arch Ophthalmol 2003,121-1684
8Terry TL, Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each cyrstalline lens. Am J Ophthalmol 1942,25-203
9Phelps DL, An estimate of vision loss in the United States-1979. Pediatrics 1981,67-924
10Patz A, Hoeck Le, De La Cruz E, Studies on the effect of high oxygen adminstration in retrolental fibroplasia Am J Ophthalmol 1952,35-1248
11Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B, Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Coopreative Group. Ophthalmology 1991,98-1628
12Schalij –Delfos NE, Cats BP, Retinopathy of prematurity:the continuing threat to vision in preterm infants. Dutch survey from 1986-1994. Acta Ophthalmologica Scand 1997,75-72
13Kulaçoglu DN, Sertöz AD, Ates O, Baykal O, Prematüre retinopatisinde risk faktörleri ve tarama sonuçlari. Ret-Vit 2005,13-33
14zcan E, Yenice , Kazokoglu H, Bavbek T, Toker E, zek E, Prematüre Retinopatisi Gelisiminde Etkili Risk Faktörleri ve Tarama Sonuçlari Ret-Vit 2006,14-127
15Gültan E, Kutluk S, nder F, Arsan S, Kural G, Prematüre Retinopatisi Gelismesinde Etkili Faktörler Ret-Vit 1996,3-619
16ner A, zkiris A, Günes T, Karaküçük S, Prematüre Retinopatisi: 2 Yillik Tarama Sonuçlarimiz. Erciyes Tip Dergisi 2005,27-104
17Apil A, Vatansever H, Oba E ve ark. : Prematüre bebeklerde retinopati insidansi ve retinopati saptanan gözlerde evre, zon iliskisi. T Oft Gaz. 2004,34-439
18Afrashi F, Erakgon T, Mentes J ve ark, Prematüre bebeklerde prematüre retinopatisi tarama sonuçlari T Oft Gaz 2005,35-150
19Mutlu FM, Altinsoy HI, Mumcuoglu T, Kerimoglu H Kiliç S, Kul M, Sarici SU, Alpay F, Screening for retinopathy of prematurity in a tertiary care newborn unit in Turkey:frequency, outcomes and risc factor analysis. J Pediatr Ophtahlmol Srabismus 2008,45-291
20Shohat M, Reisner SH, Krikler R, Nissenkom I, Yassur Y, Ben-Sira I, Retinopathy of prematurity: Incidence and risc factors. Pediatrics 1983,72-159
21Arroe M, Peitersen B, Retinopathy of prematurity: Review of a seven-year period in a Danish neonatal intensive care unit. Acta Pediatr 1994,83-501
22Patz A, Hoeck LE, De La Cruz E, Studies on the effect of high oxygen administration in retrolental fibroplasia I. Nursery observations Am J Ophthalmol 1952,35-1248
23Flynn JT, Bancalari E, Bawol R, Goldberg R, Cassady J, Schiffman J, Feuer W, Roberts J, Gillings D, Sim E ve ark, Retinopathy of prematurity Arandomized, prospective trial of transcutaneous oxygen monitoring. Ophthalmology 1987,94-630
24Stout AU, Stout JT, Retinopathy of prematurity Pediatr Clin N Am 2003,50-77
25Cryotherapy for Retinopathy of Prematurity Cooperative Group, Multicentre trial for cryoherapy for retinopathy of prematurity: one year outcome-structure and function. Arch Ophthalmol 1990,108-1408
26Cryotherapy for Retinopathy of Prematurity Cooperative Group, Multicentre trial for cryoherapy for retinopathy of prematurity: ophthalmological outcome at 10 years. Arch Ophthalmol 2001,119-110
27STOP-ROP, Multicentre Study Group. Supplemental therapeutic oxygen for pretreshold retinopathy of prematurity. (STOP-ROP), a randomized controlled trial. I: Preliminary outcomes. Pediatrics 2000,105-295
28Pierce EA, Foley ED, Smith LEH, Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996,114-1219
29McNamara JA, Tasman W, Brown GC, Federman JL, Laser photocoagulation stage 3+ retinopathy of prematurity. Ophthalmolgy 1991,98-576
30Iverson DA, Trese MT, Orgel IK, Williams GA, Laser photocoagulation for treshold retinopathy of prematurity. Arch Ophthalmol 1991,109-1342
31Yaman A, Çetin E, Berk AT, Kaynak S, Prematür Retinopatisinde Tedavi Sonuçlarimiz Ret-Vit 2004,12-122
